- Category
- Micro (2020-21)
- Udyam number
- UDYAM-TS-20-0003460

Vityl Pharmaceuticals Private Limited
About Vityl Pharmaceuticals Private Limited
Data last updated:
Vityl Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 18 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2020PTC141883.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹7 Lakh. It is led by directors Arimburath Muralidharan Nair (Managing Director) and Priya Chandran.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.1 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹5.43 Lakh (net margin 4.9%) and EBITDA of ₹7.54 Lakh (EBITDA margin 6.9%). Revenue has grown at a compounded annual rate (CAGR) of 262% over three years.
The company has about 8 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Vityl Pharmaceuticals.
Vityl Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0003460).
Company details
Recognitions & Rankings of Vityl Pharmaceuticals
Contact details
Vityl Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressD. No 5 – 9 – 350/16 Plot No. 16 2nd Floor Flat No.4, Near Yellamma Temple Registration Colony Yapral, Hyderabad, Telangana, India – 500087
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Vityl Pharmaceuticals operates one associated brand: Vityl Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmacy services focusing on compounded medications and vitamins in Hyderabad. | vitylpharma.com |
Business activity
The main business activity of Vityl Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Vityl Pharmaceuticals Private Limited, buy the company report.
Financials of Vityl Pharmaceuticals Private Limited
FY 2025 filings availableVityl Pharmaceuticals Private Limited reported revenue of ₹1.1 Cr (up 17% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 262% over three years, including 17% growth in the latest year. EBITDA fell 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹7.54 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹5.43 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 6.9% | |||
| Net Profit Margin | 4.9% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Vityl Pharmaceuticals Private Limited, buy the company report.
Board of directors of Vityl Pharmaceuticals Private Limited
Vityl Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Priya Chandran Also directs: Vityl Innovations Private Limited | Director | 18 Jul 2020 | 6 Years 3 Months | Current |
| Arimburath Muralidharan Nair Also directs: Vityl Innovations Private Limited | Managing Director | 18 Jul 2020 | 6 Years 3 Months | Current |
Peer comparison
Vityl Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Khevo Pharmaceuticals Private Limited | ₹1.1 Cr (FY 2025) | 45.0% | Pune, Maharashtra, India | |||
| Macvista Pharmaceuticals Private Limited | ₹1.1 Cr (FY 2025) | 151.0% | Hyderabad, Telangana, India | |||
| Helzon Pharmaceuticals Pvt Ltd | ₹1.1 Cr (FY 2025) | -2.0% | Kolkata, West Bengal, India | |||
| Vityl Pharmaceuticals Private Limitedthis company | ₹1.1 Cr (FY 2024) | ₹5.43 Lakh | 4.9% | 17.0% | Hyderabad, Telangana, India | |
| Deo Pharmaceuticals Private Limited | ₹1.09 Cr (FY 2024) | 53.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Vityl Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Vityl Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vityl Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Vityl Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Vityl Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Arimburath Muralidharan Nair was appointed as Managing Director on 18 Jul 2020.
Frequently asked questions
Vityl Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 18 July 2020 (6+ years old) and is registered under CIN U24230TG2020PTC141883.
Vityl Pharmaceuticals has 2 current directors:
- Arimburath Muralidharan Nair - Managing Director
- Priya Chandran - Director
The latest financial statements of Vityl Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Vityl Pharmaceuticals is U24230TG2020PTC141883. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vityl Pharmaceuticals was incorporated on 18 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Vityl Pharmaceuticals by revenue are Khevo Pharmaceuticals Private Limited, Macvista Pharmaceuticals Private Limited, Helzon Pharmaceuticals Pvt Ltd, Deo Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Arimburath Muralidharan Nair was appointed as Managing Director on 18 Jul 2020. Priya Chandran was appointed as Director on 18 Jul 2020.
Yes, Vityl Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-20-0003460).
The registered office of Vityl Pharmaceuticals is at D. No 5 – 9 – 35016 Plot No. 16 2nd Floor Flat No.4, Near Yellamma Temple Registration Colony Yapral, Hyderabad, Telangana, India – 500087.
Vityl Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Vityl Pharmaceuticals has 1 associated brand: Vityl Pharmaceuticals.